Home › Funds › Marest Capital, LLC › HOWL
Marest Capital, LLC position in HOWL
WEREWOLF THERAPEUTICS INC · Health Care
Marest Capital, LLC reported holding 10,870 shares of HOWL (WEREWOLF THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$10K, representing 0.01% of its reported portfolio and ranking #27 among its reported holdings. Marest Capital, LLC has disclosed HOWL holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-10-23 · Source: SEC EDGAR Form 13F-HR
How Marest Capital, LLC's HOWL position evolved
Marest Capital, LLC first disclosed a stake in HOWL in Q2 2026 at 10,870 shares (US$4K). The position peaked in Q3 2026 at 10,870 shares, worth US$10K. Across 2 filings, Marest Capital, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 10,870 shares valued at US$10K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 10.87K | $3.91K | New |
| Q3 2026 | 10.87K | $10.03K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HOWL and 13F data
HOWL (WEREWOLF THERAPEUTICS INC) is a Health Care company. 15 other funds we track also report a position in HOWL — the largest reported positions include DC Funds, LP (US$212.0M), Lynx1 Capital Management LP (US$237K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HOWL
- DC Funds, LP 589.10K sh · $212.02M · Q2 2026
- Lynx1 Capital Management LP 657.79K sh · $236.74K · Q2 2026
More on Marest Capital, LLC
FAQ
How long has Marest Capital, LLC held HOWL?
Marest Capital, LLC has disclosed HOWL holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Marest Capital, LLC's current position in HOWL?
As of Q3 2026, Marest Capital, LLC holds 10.87K shares of HOWL (WEREWOLF THERAPEUTICS INC), valued at $10.03K, representing 0.01% of its reported portfolio and ranking #27.
Has Marest Capital, LLC been buying or selling HOWL?
In the latest 13F filing (Q3 2026), Marest Capital, LLC held unchanged its position in HOWL. The position peaked in Q3 2026 at 10.87K shares.
Which other funds hold HOWL?
Other major institutional holders of HOWL include DC Funds, LP, Lynx1 Capital Management LP, among 15 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.